In breast cancer cells, VLDLR silencing suppresses sphere formation abilities in vitro and tumor growth in vivo. We find that VLDLR knockdown induces transition from self-renewal to quiescence.

We evaluated the effect of FKA on prostate tumor spheroid formation by prostate cancer stem cells ... Flow Cytometry Sorting and Prostasphere Formation Assays Five to ten million of 22Rv1 and DU145 ...

School of Basic Medical Science, Xi’an Key Laboratory of Pathogenic Microorganism and Tumor Immunity, Xi’an Medical University, Xi’an 710021, China School of Biotechnology and Health Sciences, Wuyi ...

Credit: Thinkstock Investigators explored the potential of a noninvasive ctDNA assay as a predictive biomarker for advanced or metastatic urothelial cancer. Increases in circulating tumor DNA ...

The ChemoFx® treatment selection marker and tumor profiling assay will initially focus on ovarian and other gynecological cancers and may include testing of other major tumor types of interest ...

(NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® drug response assay in Europe and expanded availability in the United ...

“There is still so much we need to learn about prostate cancer, and we eagerly look forward to seeing how this work progresses over the coming years.” Reference: Francis JC, Capper A, Rust AG, et al.